Showing results (41-50 of 53) with videos related to
Sort By:
Pageof 6
Gynecologic Oncology|October 11, 2023
Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomasMartin Köbel, Rui Zhe Yang, Eun Young Kang, et al.Science Advances|August 28, 2021
Genome-wide synthetic lethal screen unveils novel CAIX-NFS1/xCT axis as a targetable vulnerability in hypoxic solid tumorsShawn C Chafe, Frederick S Vizeacoumar, Geetha Venkateswaran, et al.Oncogene|April 29, 2025
A novel role for Neurog2 in MYCN driven neuroendocrine plasticity of prostate cancerPrachi Walke, Jared D W Price, Frederick S Vizeacoumar, et al.Gynecologic Oncology|July 6, 2024
Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancerPooja Praveen Kumar, DuPreez Smith, James Key, et al.Oncogene|April 28, 2018
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumoursBehzad M Toosi, Amr El Zawily, Luke Truitt, et al.Nature Communications|May 22, 2026
Initial leukemic epigenomic state determines hypomethylating agent responseAparna Gopal, Derek Tam, Franziska Mey, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 28, 2023
A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer TherapyAmr El Zawily, Frederick S Vizeacoumar, Renuka Dahiya, et al.Cancer Discovery|May 16, 2012
Essential gene profiles in breast, pancreatic, and ovarian cancer cellsRichard Marcotte, Kevin R Brown, Fernando Suarez, et al.Nature Biotechnology|March 29, 2011
Systematic exploration of essential yeast gene function with temperature-sensitive mutantsZhijian Li, Franco J Vizeacoumar, Sondra Bahr, et al.Oncotarget|August 25, 2016
Therapeutic relevance of the protein phosphatase 2A in cancerChelsea E Cunningham, Shuangshuang Li, Frederick S Vizeacoumar, et al.Pageof 6